Re: Bear
|
6
|
Resverlogix Corp.
|
Jan 14, 2020 08:47AM
|
Re: Australia Associated Press
|
3
|
Resverlogix Corp.
|
Mar 04, 2021 07:20PM
|
Re: Australia Associated Press
|
4
|
Resverlogix Corp.
|
Mar 04, 2021 07:27PM
|
Re: Australia Associated Press
|
5
|
Resverlogix Corp.
|
Mar 03, 2021 05:43PM
|
Re: Australia Associated Press
|
5
|
Resverlogix Corp.
|
Mar 03, 2021 05:48PM
|
Re: As Pfizer charges ahead....
|
2
|
Resverlogix Corp.
|
Sep 03, 2021 06:23PM
|
Re: As Pfizer charges ahead....
|
5
|
Resverlogix Corp.
|
Sep 07, 2021 07:22PM
|
Re: As Pfizer charges ahead....
|
7
|
Resverlogix Corp.
|
Sep 07, 2021 07:36PM
|
Re: As Pfizer charges ahead....
|
2
|
Resverlogix Corp.
|
Sep 04, 2021 04:26PM
|
Re: As Pfizer charges ahead....
|
3
|
Resverlogix Corp.
|
Sep 04, 2021 04:29PM
|
Re: As Pfizer charges ahead....
|
1
|
Resverlogix Corp.
|
Sep 04, 2021 04:30PM
|
Re: As Pfizer charges ahead....
|
4
|
Resverlogix Corp.
|
Sep 06, 2021 02:19PM
|
Re: Article
|
9
|
Resverlogix Corp.
|
May 29, 2022 04:26PM
|
Re: archived presentation is up. still no audio
|
4
|
Resverlogix Corp.
|
Nov 18, 2019 02:04PM
|
Re: archived presentation is up. still no audio
|
3
|
Resverlogix Corp.
|
Nov 18, 2019 02:46PM
|
Re: archived presentation is up. still no audio
|
2
|
Resverlogix Corp.
|
Nov 18, 2019 02:51PM
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
5
|
Resverlogix Corp.
|
Mar 03, 2021 05:16PM
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
5
|
Resverlogix Corp.
|
Mar 03, 2021 05:16PM
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
12
|
Resverlogix Corp.
|
Mar 03, 2021 12:37PM
|
Re: Apabetalone and Alkaline Phosphatase
|
4
|
Resverlogix Corp.
|
Oct 12, 2019 11:00AM
|